EC approves subcutaneous formulation of Entyvio as maintenance therapy in ulcerative colitis or Crohn’s disease

This article was originally published here

Entyvio SC will be made available in both a pre-filled syringe and a pre-filled pen. UC and CD are two of the most common forms of inflammatory bowel

The post EC approves subcutaneous formulation of Entyvio as maintenance therapy in ulcerative colitis or Crohn’s disease appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply